{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:04:12Z","timestamp":1776171852687,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15702-2","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:35:41Z","timestamp":1772584541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung cancer treatment pathways in the largest private health insurance in Brazil: a real-world data study"],"prefix":"10.1186","volume":"26","author":[{"given":"Rodrigo Afonso","family":"da Silva Sardenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Augusto Lima","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breno Cordeiro","family":"Porto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Arnaldo Shiomi","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"3","key":"15702_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"15702_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"15702_CR3","first-page":"170","volume":"15","author":"C Mathias","year":"2020","unstructured":"Mathias C, Prado GF, Mascarenhas E, Ugalde PA, Zimmer Gelatti AC, Carvalho ES, et al. Lung cancer in Brazil. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2020;15(2):170\u20135.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"9779","key":"15702_CR4","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(11)60054-8","volume":"377","author":"J Paim","year":"2011","unstructured":"Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet Lond Engl. 2011;377(9779):1778\u201397.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"15702_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/cam4.1896","volume":"8","author":"DF Sheehan","year":"2019","unstructured":"Sheehan DF, Criss SD, Chen Y, Eckel A, Palazzo L, Tramontano AC, et al. Lung cancer costs by treatment strategy and phase of care among patients enrolled in medicare. Cancer Med. 2019;8(1):94\u2013103.","journal-title":"Cancer Med"},{"issue":"9","key":"15702_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jnci\/djn103","volume":"100","author":"KR Yabroff","year":"2008","unstructured":"Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, et al. Cost of care for elderly cancer patients in the united States. J Natl Cancer Inst. 2008;100(9):630\u201341.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"15702_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jgo.2019.07.017","volume":"11","author":"MS Sedrak","year":"2020","unstructured":"Sedrak MS, Mohile SG, Sun V, Sun CL, Chen BT, Li D, et al. Barriers to clinical trial enrollment of older adults with cancer: A qualitative study of the perceptions of community and academic oncologists. J Geriatr Oncol. 2020;11(2):327\u201334.","journal-title":"J Geriatr Oncol"},{"key":"15702_CR8","doi-asserted-by":"crossref","unstructured":"Baldotto CSR, Julian GS, Mascarenhas E, Laloni MT, de Azevedo CRAS, Kashiura D et al. Padr\u00f5es de tratamento, Uso de recursos e custo do c\u00e2ncer de pulm\u00e3o de n\u00e3o pequenas c\u00e9lulas avan\u00e7ado Em institui\u00e7\u00f5es Brasileiras Privadas. J Bras Econ Sa\u00fade Impr. 2018;86\u2013106.","DOI":"10.21115\/JBES.v10.n2.p86-106"},{"key":"15702_CR9","first-page":"100153","volume":"7","author":"B Fonseca","year":"2022","unstructured":"Fonseca B, de Albuquerque P, Saldanha PC, de Zicker R. Geographic accessibility to cancer treatment in brazil: A network analysis. Lancet Reg Health Am. 2022;7:100153.","journal-title":"Lancet Reg Health Am"},{"issue":"11","key":"15702_CR10","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3390\/cancers16112068","volume":"16","author":"J Gin\u00e9s Rubi\u00f3","year":"2024","unstructured":"Gin\u00e9s Rubi\u00f3 J, Delgado O, Callejo A, Dom\u00ednguez M, Torres C. Healthcare resource utilization and associated costs among patients with advanced Non-Small-Cell lung cancer receiving chemotherapy or immunotherapy in spain: A Single-Center, Real-World, exploratory study. Cancers. 2024;16(11):2068.","journal-title":"Cancers"},{"issue":"1","key":"15702_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5334\/aogh.2419","volume":"85","author":"JA Barta","year":"2019","unstructured":"Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health. 2019;85(1):8. https:\/\/doi.org\/10.5334\/aogh.2419. PMID: 30741509; PMCID: PMC6724220.","journal-title":"Ann Glob Health"},{"issue":"35","key":"15702_CR12","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1080\/14796694.2024.2390821","volume":"20","author":"A Ferreira-Gonzalez","year":"2024","unstructured":"Ferreira-Gonzalez A, Ko G, Fusco N, Stewart F, Kistler K, Appukkuttan S, et al. Barriers and facilitators to next-generation sequencing use in united States oncology settings: a systematic review. Future Oncol Lond Engl. 2024;20(35):2765\u201377.","journal-title":"Future Oncol Lond Engl"},{"issue":"4","key":"15702_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s41669-023-00407-0","volume":"7","author":"J Vanderpoel","year":"2023","unstructured":"Vanderpoel J, Emond B, Ghelerter I, Milbers K, Lafeuille MH, Lefebvre P, et al. Healthcare resource utilization and costs in patients with EGFR-Mutated advanced Non-Small cell lung cancer receiving First-Line treatment in the united states: an insurance Claims-Based descriptive analysis. PharmacoEconomics - Open. 2023;7(4):617\u201326.","journal-title":"PharmacoEconomics - Open"},{"key":"15702_CR14","doi-asserted-by":"crossref","unstructured":"Zeng Q, Wang B, Li J, Zhao J, Mao Y, Gao Y, Solid nodule appearance as a predictor of tumor spread through air spaces in patients with lung adenocarcinoma: A propensity score matching study. Cancer Manag Res., Li Q, Zhao J, Mao J, Gao Y, Xue Y, Gao Q, Sun S, He N et al. J., prof.jiehe@gmail.com) Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China):8197\u2013207.","DOI":"10.2147\/CMAR.S266750"},{"issue":"1","key":"15702_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3892\/mco.2021.2439","volume":"16","author":"C Martin","year":"2022","unstructured":"Martin C, Cuello M, Barajas O, Recondo G, Aruachan S, Perroud H, et al. Real-world evaluation of molecular testing and treatment patterns for EGFR mutations in non-small cell lung cancer in Latin America. Mol Clin Oncol. 2022;16(1):6. Epub 2021 Nov 12. https:\/\/doi.org\/10.3892\/mco.2021.2439. PMID: 34881026; PMCID: PMC8647188.","journal-title":"Mol Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15702-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:23:39Z","timestamp":1776169419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15702-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15702"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15702-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the National Research Ethics Commission (CONEP), National Health Council, Ministry of Health, Brazil (CAAE: 82712024.1.0000.0229). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the Brazilian National Health Council Resolution No. 466\/2012. Given the retrospective design and the use of anonymized secondary data, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its publication.Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}